(IBHH) iShares iBonds 2028 Term - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E3870

High-Yield, Corporate, Bonds, 2028, Maturity

Description: IBHH iShares iBonds 2028 Term October 28, 2025

The iShares iBonds 2028 Term High Yield and Income ETF (BATS:IBHH) tracks an index of U.S.-dollar-denominated, taxable, fixed-rate corporate bonds that are rated high-yield or BBB (or equivalent) and have maturities strictly between January 1 2028 and December 15 2028. To fully replicate the index, the fund may also hold bonds issued by non-U.S. entities, and it is classified as a non-diversified ETF.

As of the most recent data (Q3 2024), the fund’s weighted average maturity is 2.9 years, and its effective duration sits around 2.5, reflecting modest interest-rate sensitivity. The current yield-to-worst is approximately 5.8%, which is roughly 1.2 percentage points above the Bloomberg U.S. Treasury 2-year benchmark, indicating a credit spread premium that compensates investors for higher default risk.

Key macro drivers for IBHH’s performance include the Federal Reserve’s policy trajectory and the broader economic cycle. A tightening cycle that pushes the Fed funds rate above 5% would likely compress high-yield spreads, while a recession-induced slowdown in corporate earnings could widen defaults and widen spreads, especially in cyclical sectors such as energy and consumer discretionary, which together account for about 30% of the portfolio’s weight.

Given its non-diversified status, concentration risk is a material consideration; the top five issuers represent roughly 18% of assets, so investors should monitor issuer-specific credit developments closely.

For a deeper, data-driven assessment of IBHH’s risk-adjusted return profile, you might explore the ValueRay platform’s interactive credit-spread analytics.

IBHH ETF Overview

Market Cap in USD 348m
Category Target Maturity
TER 0.35%
IPO / Inception 2022-03-08

IBHH ETF Ratings

Growth Rating 78.2%
Fundamental -
Dividend Rating 70.5%
Return 12m vs S&P 500 -6.72%
Analyst Rating -

IBHH Dividends

Dividend Yield 12m 6.55%
Yield on Cost 5y 7.91%
Annual Growth 5y 16.92%
Payout Consistency 100.0%
Payout Ratio %

IBHH Growth Ratios

Growth Correlation 3m 72.1%
Growth Correlation 12m 92.4%
Growth Correlation 5y 93.7%
CAGR 5y 9.16%
CAGR/Max DD 3y (Calmar Ratio) 1.94
CAGR/Mean DD 3y (Pain Ratio) 12.38
Sharpe Ratio 12m 1.21
Alpha -5.12
Beta 0.570
Volatility 3.20%
Current Volume 45.3k
Average Volume 20d 61.5k
Stop Loss 22.9 (-3%)
Signal 0.78

What is the price of IBHH shares?

As of November 07, 2025, the stock is trading at USD 23.61 with a total of 45,262 shares traded.
Over the past week, the price has changed by +0.04%, over one month by -0.13%, over three months by +1.40% and over the past year by +7.07%.

Is iShares iBonds 2028 Term a good stock to buy?

Yes. Based on ValueRay's Analyses, iShares iBonds 2028 Term (BATS:IBHH) is currently (November 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.19 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBHH is around 24.22 USD . This means that IBHH is currently overvalued and has a potential downside of 2.58%.

Is IBHH a buy, sell or hold?

iShares iBonds 2028 Term has no consensus analysts rating.

What are the forecasts/targets for the IBHH price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.9 14%

IBHH Fundamental Data Overview October 27, 2025

Market Cap USD = 348.5m (348.5m USD * 1.0 USD.USD)
Beta = 0.57
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 348.5m USD (348.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 348.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 348.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.12% (E(348.5m)/V(348.5m) * Re(8.12%) + (debt-free company))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBHH ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle